Alveolar Macrophages Have a Protective Antiinflammatory Role during Murine Pneumococcal Pneumonia
Authors:
- 15 January 2003
- journal article
- research article
- Published by Oxford University Press (OUP) in American Journal of Respiratory and Critical Care Medicine
- Vol. 167 (2) , 171-179
Abstract
Alveolar macrophages (AMs) are considered major effector cells in host defense against respiratory tract infections by virtue of their potent phagocytic properties. In addition, AMs may regulate the host inflammatory response to infection by production of cytokines and by their capacity to phagocytose apoptotic polymorphonuclear cells (PMNs). To elucidate the in vivo contribution of AM to host defense against pneumococcal pneumonia, we depleted mice of AMs via pulmonary application of liposomal dichloromethylene-bisphosphonate (AM− mice) before inoculation with Streptococcus pneumoniae; control mice received saline (AM+sal) or liposomal phosphate-buffered saline (AM+lip) before bacterial inoculation. AM− mice displayed a significantly higher mortality compared with AM+ control mice, whereas bacterial clearance did not differ. Poor outcome of AM− mice was accompanied by a pronounced increase of local proinflammatory cytokine production as well as strongly elevated and prolonged pulmonary PMN accumulation. Closer examination of infiltrating PMN in AM− mice disclosed high proportions of apoptotic and secondary necrotic cells, reflecting the lack of efficient clearance mechanisms in the absence of AMs. Furthermore, caspase-3 staining showed only slightly higher activity in AM− mice, arguing against accelerated apoptosis per se. These data suggest that AMs are indispensable in the host response to pneumococcal pneumonia by means of their capacity to modulate inflammation, possibly via elimination of apoptotic PMNs.Keywords
This publication has 45 references indexed in Scilit:
- The Role of Interferon‐γ in Murine Pneumococcal PneumoniaThe Journal of Infectious Diseases, 2002
- Cytokine immunotherapy during bacterial pneumonia: From benchtop to bedside1Seminars in Respiratory Infections, 2001
- Role of Pulmonary Alveolar Macrophages in Defense of the Lung againstPseudomonas aeruginosaInfection and Immunity, 2000
- Intracellular Trafficking and Killing ofStreptococcus pneumoniaeby Human Alveolar Macrophages Are Influenced by OpsoninsInfection and Immunity, 2000
- Serial killers: ordering caspase activation events in apoptosisCell Death & Differentiation, 1999
- Monocyte chemotactic factors released from type II pneumocyte-like cells in response to TNF-alpha and IL-1alphaEuropean Respiratory Journal, 1999
- Caspases: Enemies WithinScience, 1998
- Drug‐ResistantStreptococcus pneumoniaeClinical Infectious Diseases, 1998
- Macrophages that have ingested apoptotic cells in vitro inhibit proinflammatory cytokine production through autocrine/paracrine mechanisms involving TGF-beta, PGE2, and PAF.Journal of Clinical Investigation, 1998
- MUCOSAL IMMUNOADJUVANT ACTIVITY OF LIPOSOMES: ROLE OF ALVEOLAR MACROPHAGESImmunology, 1996